Shaping of the proteome by alternative translation is an important mechanism of posttranscriptional gene regulation. It can lead to the expression of multiple protein isoforms originating from the same mRNA. Here we show that a novel, abundant and long isoform of the stress/p38 MAPK -activated kinase MK2, a key regulator of transcription, migration, death signaling and post-transcriptional gene regulation, is constitutively translated from an alternative CUG translation initiation start site located in the 5'UTR of its mRNA. GC-rich sequences and putative G-quadruplex structures influence the usage of that codon as a translation initiation start site and the RNA helicase eIF4A1 is needed to ensure alternative isoform translation. We recapitulated the usage of the alternative start codon and determined the molecular properties of the short and a long MK2 isoforms. Phenotypically, only the short isoform phosphorylated Hsp27, supported migration and stress-induced immediate early gene (IEG) expression. Interaction profiling by quantitative mass-spectrometry revealed short isoform-specific binding partners that were associated with migration. In contrast, the long isoform contains additional putative phosphorylation sites in its unique N-terminus. In sum, our data reveal a longer and previously non-described isoform of MK2 with distinct physiological properties originating from alternative translation.
Introduction
Post-transcriptional gene regulation (PTGR) constitutes an important toolbox used to shape gene expression upon intra-and extracellular cues. PTGR impacts on mRNA processing, localization, export, stability and translation. Canonical translation of mRNAs starts on AUG translation initiation sites (TIS) that are recognized by ribosomes through scanning of the 5' UTR leader sequence and is dependent on the cap-structure. Translation initiation and the production of protein isoforms by alternative translation mechanisms are highly regulated.
They are influenced by sequences in the 5' untranslated region (5'UTR) bearing internal ribosomal entry sites (IRES), secondary structures, upstream open reading frames (uORFs) or by "leaky scanning" of sequences preceding the initiator AUG (Kozak sequence), leading to the usage of alternative start codons (1, 2) . Additionally, numerous translation events at non-AUG start codons have been detected in mRNAs determining alternative translation initiation sites (aTIS) sequences (3, 4) . The mechanisms by which ribosomes select non-AUG codons for translation initiation might rely on uORFs, structured 5'UTRs (5) or translation initiation auxiliary factors and RNA helicases such as eIF4A1, eIF2A or Ddx3 (6) (7) (8) . Taken together these features of translation explain in part how proteome diversity in cells can be generated from a limited number of transcripts.
Protein kinases and associated signal transduction pathways play an important role in regulating transcriptional and post-transcriptional events. A well-characterized pathway is the p38 MAPK -MK2-signaling module. The p38 MAPK -activated kinase MK2 (or MAPKAPK2)
phosphorylates substrates such as the RNA-binding protein and PTGR master regulator tristetraprolin (TTP) and the transcription factor serum response factor (SRF) (9) . Numerous reports characterize the diverse functions of MK2 in inflammation and stress signaling (10) , also suggesting its role as a checkpoint kinase in cancer (11) . Powerful tools for these studies are the MK2 knockout (MK2 KO) (12) and the MK2/3 double knockout (MK2/3 DKO) (13) mouse models and, consequently, many phenotypes could be detected with the help of these animals. These phenotypes range from defects in immediate early gene responses over impaired cytokine production and regulation of apoptosis/necroptosis to non-coding RNA regulation and defects in migration. The above mentioned phenotypes could be linked to specific substrates of MK2, such as the above mentioned TTP (14) and SRF (15) , RIPK1 (16) (17) (18) and RBM7 (19, 20) .
Western blot detection of endogenous MK2 often gave two bands where only the lower band represented the apparent molecular mass of the kinase (21,22). Interestingly, ectopically expressed MK2 does not display the second, slower migrating band. To date, no information about the nature of this MK2 isoform expression is available. By exploiting RNA sequencing (RNASeq), ribosome footprinting (RiboSeq) and by conducting biochemical assays, we show that the long MK2 isoform constitutively arises from alternative translation of an in-frame upstream CUG alternative translation initiation site (aTIS) in the highly structured and conserved GC-rich 5'UTR. The CUG is surrounded by an alternative Kozak sequence, and the helicase eIF4A1 is needed to secure translation of both the CUG-and AUG-initiated isoforms. Mechanistically, the long and short MK2 isoforms engage in distinct protein-protein interactions and rescue MK2-deficiency phenotypes to different extents in vivo. Therefore, our results resolve the controversy surrounding an additional high molecular weight MK2 band often noted since its discovery in the 1990s (21,22).
Results

Translation of MK2 from an alternative start codon in the 5'UTR of its mRNA
MK2 is a ubiquitously expressed p38 MAPK -activated protein kinase (10) . When analyzing its expression in different cell lines of murine and human origin or in mouse tissues by Western blotting, a multiple band pattern is detected (Fig. 1A ,B, S1). Of note, the ratio of isoform expression is distinct and the intensities of the lower and upper band vary between tissues and cell lines. In murine cells and tissues, two predominant bands of approximately 50 and 60 kDa can be detected in Western Blot by using an anti-MK2 antibody directed towards the CTerminus of human MK2 (Fig. 1A,B) . The low molecular weight isoform corresponds to the hitherto known open reading frame (ORF) of the gene, whereas the origin and function of the slower migrating isoform is obscure, and only one transcript existed in the NCBI database (NM_008551.2). Importantly, both bands were found to be absent in cells from MK2 knockout (KO, described in (12) ) and MK2/3 double knockout mice (DKO, described in (13)) (Fig. 1A, S1A ). In human cell lines two dominating bands of around 55 kDa together with two less intense bands at around 65 kDa were detected (Fig. 1A , S1C,D). Two similar human MK2 transcripts (NM_004759.4 and NM_032960.3) can be found in the database and arise from alternative splicing. shRNA-mediated knockdown of human MK2 in HT29 cells removed all of these bands confirming that they were derived from the same gene (Fig. S1D ).
For the murine MK2-related protein kinase MK3 only one specific protein product is detected and this is absent in MK2/3 DKO cells (Fig. S1A,B ). Taken together, we concluded that the different MK2 protein bands can be assigned to distinct protein isoforms that may originate from post-translational modifications of MK2, alternative splicing or alternative translation events.
To test the hypothesis of the existence of alternative translation products, we exploited existing RNA sequencing (RNASeq) and ribosome footprinting (RiboSeq) data from different cell lines. Initially, our own data from murine bone marrow-derived macrophages (BMDMs) (23) were reanalyzed and revealed the existence of an MK2 transcript with an extended 5´UTR that also contained several ribosome footprints (RFPs) within this region (Fig. 1C) .
This supported the idea of the existence of alternative translation events in the 5´UTR. In fact, an extended MK2 transcript that corresponded to the transcript length we detected by RNASeq, was recently deposited at NCBI (NM_008551.2) and replaced the previously annotated transcript having only a very short 18 nt 5´UTR (NM_008551.1; Fig. 1C ). The analysis of this transcript showed a potential in-frame extension of the hitherto known MK2 ORF in the upstream direction (Fig. 1D ). Within this extension we found two putative alternative translation initiation start sites (aTIS) at positions -141 and -309, coding for Leucine (CUG) and Valine (GUG), respectively. The CUG and GUG are surrounded by the alternative Kozak-sequences GCCGAGCCUGGAG and GCAGCCTGUGACG (3).
Consistent with the Western blot results, RFPs and sequences analyses revealed an in-frame extension in the 5'UTR of the human MK2 transcript bearing the two alternative start codons CUG and GUG (Fig. S2A,B) . Interestingly, in the human transcript, the CUG is in almost the same distance to the AUG (-144bp, -48Aa). Overall, more than 80% sequence identity within the first 200bp upstream of the start AUG codon exists between the murine and human 5'UTR ( Fig. S2C ). Further sequence analyses showed that the 5´UTR extension is evolutionary conserved among species, indicating a distant origin for alternative translation of MK2 isoforms (Supplementary File S1). This observation was supported by analyzing published RiboSeq data sets of murine and human cells that were either treated with cycloheximide, harringtonine or lactimidomycin before sequencing of ribosome-protected mRNA fragments (8, (24) (25) (26) (27) (28) (29) . Since mRNA bound ribosomes are frozen at translation initiation start sites by these treatments as previously exemplified in pioneering RiboSeq studies (30,31), the existence of footprints in the 5´UTR of MK2 strongly argues for alternative translation events.
Indeed, we could observe such footprints in murine and human cell lines in the 5'UTR of MK2 ( Fig. S3 and 4) .
To validate the existence of an N-terminally extended MK2 isoform due to alternative translation initiation, we sought to purify endogenous MK2 from murine RAW264.7 cells that express almost equal levels of both MK2 isoforms (Fig. 1A,E) . By using a MK2-Nanotrap (Chromotek, München, Germany) we were able to enrich and purify considerable amounts of endogenous MK2 from these cells and subsequently analyzed the purified protein by massspectrometry (Fig. 1E,F) . We readily identified peptides derived from the predicted in-frame 5´UTR extension originating from the CUG aTIS at position -141 (Fig. 1F ). The detection of peptides derived from sequences further upstream of this CUG indicates that also the GUG in position -309 or other codons may be used for alternative translation initiation. In sum, these results confirmed the existence of at least one aTIS at position -141 in the 5´UTR of the MK2 transcript resulting in the translation of a minimum of two distinct MK2 isoforms in murine and human cells from one mRNA.
Mechanistic insights into regulation of MK2 translation
To further characterize the usage of the putative aTIS at position -141 of MK2 mRNA, we fused the extended endogenous murine 5´UTR with the known ORF sequence of murine MK2
and expressed the construct in HeLa and U2OS cells. The high GC-content of the 5´UTR (>85%) prompted us to introduce a synthetic DNA flanked by restriction sites (Fig. S5A) .
Expression of the 5´UTR-MK2-ORF construct resulted in the two-band pattern seen for endogenous murine MK2 independent of the expressing cell line ( Fig. 2A, S5B ). Mutagenesis of the putative aTIS in positions -141 and -309 resulted in an altered band pattern and revealed that the triplet CUG at -141 is used for alternative translation initiation under these conditions leading to expression of the long isoform ( Fig. 2A) . Of note, destroying the alternative Kozak-sequence surrounding this aTIS (mutation GAG to CAU) impaired the expression of the long isoform ( Fig. 2A, lane 6 ). Interestingly, it was even possible to generate an extralong MK2 isoform (super-long) by mutating -309 GUG to AUG (Fig. 2A,   lane 7) .
Next, we explored the underlying molecular mechanism responsible for differential MK2 isoform translation in vivo. Human cells treated with the anti-cancer drug silvestrol respond with a decrease in the translation of a selective set of mRNAs due to inhibition of the RNA helicase eIF4A1 (32,33). Amongst them, MK2 mRNA is a major target (33). Additionally, it was shown that mRNAs commonly regulated by this mechanism, contain long and GC-rich 5'UTRs with G-rich quadruplex structures (32,33). We were able to detect putative sequences that give rise to such structures within the 5'UTR of human and murine MK2, located within the coding and assumed non-coding region of the elongated 5'UTR (Table S1 ). We therefore speculated that the helicase eIF4A1 might play a role in selective MK2 isoform translation.
Upon depletion of eIF4A1 in murine and human cells a marked decrease in translation of both MK2 isoforms was observed (Fig. 2B, S6A ). Similar results were obtained in WT MEFs, NIH3T3 and HEK293T cells (data not shown). To additionally prove a role for the GC-rich clusters in isoform translation, we generated a mutant of the above-mentioned construct lacking the first three GC-rich clusters (positions 21, 96 and 128, see Table S1 and schematic representation of the constructs, Fig. S6B ) upstream of CUG in -141 position (DGC 5'UTR).
These deletions were accompanied by the almost complete abrogation of long isoform translation ( Fig 2C) . It was proposed that the translation initiation auxiliary factor eIF2A is important for non-AUG translation initiation (7) and expression of PTEN-alpha isoforms are dependent of this factor (34,35). However, we did not observe any effect of eIF2A depletion on MK2 isoform translation (Fig. S6C ). Epigenetic markers of mRNAs, such as m 6 -adenosine methylation, influence stability and translation of modified mRNAs (36). Human MK2 mRNA is heavily methylated near the stop codon and translation of MK2 mRNA was reported to be strongly decreased upon depletion of the methyltransferase Mettl3 (37,38).
However, we were not able to support these findings, as knockdown of Mettl3 in murine and human cell lines did not change the normal pattern of MK2 translation (Fig. S6D ). In summary, we demonstrate a role for the RNA helicase eIF4A1 and putative G-rich quadruplex structures in the generation of distinct MK2 isoforms from a single mRNA species (cf. Fig. 2D ).
Functional characterization of MK2 isoforms
In order to address the physiological consequences of MK2 isoform expression, we stably reconstituted MK2-deficient mouse embryonic fibroblasts (MEFs) cell lines (13) with the short, the long, the super-long isoform or with both (long and short) isoforms of MK2 (Fig.   3A ). First, we assessed the relative stability of the two MK2 isoforms after a cycloheximideinduced block of de novo protein translation (Fig. 3B ). As seen, the longer variant was considerably more stable than the short isoform in this assay. Both GFP-tagged isoforms localized similarly in non-stressed cells (Fig. S7A) , and when we activated p38 MAPK by anisomycin stress, we observed their similar redistribution to the cytosol confirming previous observations (summarized in (39)). Monitoring the redistribution of the super-long isoform was not possible since transfection of this construct was accompanied by short and long isoform expression (Fig. S7A) . We then tested the ability of the isoforms to phosphorylate the known MK2 substrates Reticulon 4B/NOGO-B and Hsp27 (also HSBP1 or Hsp25 in mice)
upon activation by anisomycin in cells (Fig. 3C, S7B ). The specificity of phosphorylation was assessed with chemical inhibitors of p38 MAPK -and MK2 (Fig. 3C ). While NOGO-B was readily phosphorylated by both isoforms, phosphorylation of the small heat shock protein Hsp27, a bona fide substrate of MK2, could only be detected for the short MK2 isoform, (Fig.   3C ). This finding indicated the intriguing possibility that both isoforms differed in their substrate specificity.
Taken together we were able to reconstitute MK2-deficient cells with individual isoforms.
Both murine versions of MK2 share molecular properties such as the ability to translocate from the nucleus to the cytoplasm but differ in their stability and substrate specificity.
Phenotypical consequences of MK2 isoform expression
Expression of both isoforms differ markedly among mouse tissues (Fig. 1A,B) . Therefore, we speculated on physiological relevant differences and attempted to explore the phenotypical consequences of isoform expression in MK2-and MK2/3-deficient MEFs. We initially tested proliferation of the differently rescued cell lines (Fig. S8) . Cells grew to a similar extent independently of the isoform used for rescue. We then checked the induction of the IEGs early growth response 1 (Egr1), FBJ osteosarcoma oncogene (cFos) and tristetraprolin (TTP or Zfp36) upon anisomycin stimulation of MK2/3-deficient MEFs rescued with the different isoforms of MK2 (Fig. 4A ). While expression of the short isoform markedly elevated the expression of all of these genes, the long isoform of MK2 was not able to induce IEGs. Of note, we were not able to detect differences in SRF phosphorylation by the isoforms (data not shown) indicating that other MK2-dependent mechanisms regulate IEG transcription under these conditions. Since it is known that the N-terminus of MK2 plays an important role in cell motility (40), we also assayed for cell migration in the rescue cell lines using a scratch assay (Fig. 4B ). As seen, the MK2-associated migration phenotype could only be rescued by the short but not the long MK2 isoform, consistent with our observation that only the short isoform of MK2 is competent for phosphorylation of the migration associated substrate Hsp27 (Fig. 3C ).
Collectively these results highlighted differential functional properties of alternatively translated MK2 isoforms.
MK2 isoform interaction profiling
The phenotypic differences in our rescue cell lines suggested that the two MK2 isoforms GO term analysis (data not shown) revealed more proteins, such as Smtn, Arpc2 or Ddx58, involved in migration to selectively interact with the short MK2 isoform (Fig. 4D ). Given the fact that MK2-dependent migration is only rescued by the short isoform, which is also uniquely capable of phosphorylating Hsp27 upon stress ( Fig. 3B ), we speculate that these short isoform-specific interactions underlie the migration of MK2-proficient cells. In line with our biochemical experiment ( Fig. 3C ), our proteomics analysis confirmed that both MK2 isoforms readily interact with p38alpha/beta (Mapk11/14) in a stimulus-independent manner (Fig. 4D ).
Taken together, these results revealed that the two MK2 isoforms have both common and distinct interaction partners. The specific interactions of the short isoform with migrationassociated proteins and transcriptional regulators may explain why some MK2-dependent phenotypes are only rescued by this MK2 variant.
Discussion
The p38 and harringtonine. This showed us that we not only detect translating, but also initiating ribosomes occupying these sites. Detection of endogenous peptides by mass-spectrometry that could be mapped to the potential in-frame sequence upstream of the AUG start codon supported the in silico analyses.
Two reports identified MK2 as a target of eIF4A1 with G-rich quadruplex structures in its 5'UTR, by either knocking down or inhibiting the RNA helicase with the anticancer drug silvestrol (32,33). RNA G-rich quadruplex structures in 5´UTRs are known to influence translation (41) . We found six potential sites within the full and extended 5´UTR (Table S1 ).
The human MK2 sequence bears the optimal 12-mer G-rich quadruplex sequence and its translation efficiency is strongly decreased upon treatment with silvestrol (33). Indeed, our data confirms that eIF4A1 and GC-rich sequences that might form G-rich quadruplex structures regulate MK2 translation. More specifically, these sequences upstream of the AUG translation initiation site, lead to the usage of a CUG triplet as an alternative translation initiation site within the 5'UTR of the MK2 mRNA. By deleting the GC-rich sequences upstream of the CUG, translation of the high molecular weight MK2 isoform was abrogated.
The data could suggest that the scanning mechanism of the ribosome is slowed down and consequently a leaky scanning leads to the usage of the CUG for translation initiation. This mechanism appears evolutionarily conserved, yet murine cells produce relatively more of the long and alternative isoform compared to their human counterparts. This correlates with the fact that the human 5'UTR is shorter than in the murine transcript and the CUG is only surrounded by one putative upstream G-rich quadruplex structure. The resulting decrease in structural barriers is likely accompanied by less translation from the aTIS and, consequently, the production of relatively lower amounts of the long MK2 isoform in human cells. Of note, the balance between MK2 isoform production differs markedly between murine tissues and cell lines, suggesting that these proteins have some non-overlapping functions in vivo.
mRNA adenosine methylation (N6-methyladenosine or m 6 -A, respectively) of the MK2 mRNA near the stop codon by METTL3 was reported to lower translation without affecting the mRNA level, and this effect was independent of m 6 -A reader proteins such as YTHDF1,2 and 3 (37,38). In the present study, we could not confirm an involvement of METTL3 in general or specific MK2 isoform translation. Examples of in-frame N-terminal protein extensions originating from alternative translation starting in the 5'UTR have previously been described i.e. for PTEN (34,35) or Thioredoxin/Glutathion (42) . It was suggested that eIF2A is a specificity factor for the translation of the long PTEN alpha isoform (34,35) and a general factor for non-AUG translation initiation (7, 8) . To this end we could not observe an involvement of eIF2A in elongated MK2 isoform translation. The model in Figure 2D summarizes our investigations on MK2 translation and it remains to be clarified whether the RNA helicase Ddx3 (6) is a regulatory factor for MK2 isoform translation alone or in cooperation with eIF4A (43).
The two MK2 isoforms identified in this report are highly similar in terms of their activation by and interaction with the upstream kinase p38 MAPK . The long MK2 isoforms had a decreased turnover as compared to its short counterpart, but it failed to phosphorylate the MK2 bona fide substrate Hsp27 upon anisomycin stimulation. This is similar to the different p38 MAPK isoforms, that exhibit distinct substrate specificities although displaying a high degree of amino acid sequence identity (44) . Testing potential phenotypical consequences of selective isoform expression in an MK2-deficient background revealed that only reintroduction of the short isoform or both isoforms in parallel (equal to the wildtype situation) can rescue migration defects and IEGs expression. By determining the interaction partners of MK2 isoforms, we were able to shed some light on these phenotypical differences.
The preferred binding of the short MK2 isoform to proteins of the cytoskeleton and the transcription machinery correlates with the unique ability of this isoform to rescue migration and transcriptional defects. Both processes are well-established MK2-dependent responses (15, 45) and the importance of the canonical MK2 N-terminus was confirmed here (40).
Although not elucidated in this study, the long isoform of MK2 is likely to have unique functions as well, which are not supported by the canonical isoform. Of note, the unique Nterminal extension of this protein contains putative proline-directed serine and threonine phosphorylation sites, that we could detect in their phosphorylated form in our massspectrometry data set. Interestingly, the phosphorylation of these sites seems not induced by anisomycin-stimulated p38 MAPK activation. Such additional and isoform-specific modifications could potentially allow for the recruitment of unique substrates, and the assignment of unique functions of the long MK2 isoform clearly warrants future investigation.
We therefore entertain the possibility that the extended N-terminus is targeted by other proline-directed kinases than p38 MAPK such as cyclin-dependent kinases (CDKs) (46) . We can only speculate on the consequences of extended N-terminus phosphorylation, but want to stress that expression of the short isoform alone was often accompanied by a "super-rescue" of MK2-deficiency compared to the rescue by expression of both isoforms together (see Fig.   4A ,B).
Future phospho-proteomic studies could shed additional light on substrate specificities for the two MK2 isoforms and their consequences in vivo. In addition, the generation of gene-edited mice that exclusively express either MK2 isoform could help to resolve these outstanding issues.
In conclusion, our work reveals the abundant alternative translation of a hitherto unrecognized MK2 isoform with distinct functional properties, highlighting that the biology of this important kinase is still not fully understood. Our work also resolves a long-standing mystery surrounding the presence of the additional high-molecular weight MK2 band often detected in Western blot (13, 21, 22) .
Experimental Procedures Tissue culture, cell lines, treatments
Cells were grown on plates in DMEM or in RPMI for suspension cells in the presence of 10 % (v/v) FCS, 100 U penicillin G/mL, and 100 mg/mL streptomycin (all purchased from Life Technologies) in a humidified atmosphere at 37°C with 5% CO2 supplementation. Treatments with stimulators and inhibitors were done at the following final concentrations: Anisomycin, 10 µg/ml, dissolved in DMSO, Sigma; BIRB796, 1 µM, dissolved in DMSO (Axon Medchem); MK2 inhibitor PF3644022 (10µM, Sigma) dissolved in DMSO; Cycloheximide, 20 µg/ml, dissolved in water, Sigma. For gene expression experiments cells were starved in serum-free medium for a minimum of 8h. MK2-deficient and MK2/3 double-deficient MEFs were described before (13, 15) . All other standard laboratory cell lines were either kind gifts or obtained from ATCC.
Isolation of mouse organs/bone marrow-derived macrophages
Organs of a wildtype and bone-marrow of wildtype, MK2 KO and MK2/3 DKO animals (C57BL/6 background) (12) were isolated after sacrificing them. Handling of mice complied with all relevant ethical regulations and was approved by the ethics committees of Hannover Medical School. Organs were flash-frozen in liquid nitrogen before lysis. To derive macrophages from bone marrow after the femurs of one mouse of each genotype were flushed. Cells were then grown in the presence of 10 ng/ml M-CSF for approximately 9-10 days before using them for further experiments (14) .
Transfection of cell lines
Cells were seeded the day before transfection to reach 50% density on the next day. The medium was then changed to penicillin/streptomycin-free. DNA was mixed in Opti-MEM (Life Technologies) and complexed with polyethylenimine (PEI, 1 µg/ml, pH 7.0, Sigma).
After a minimal incubation of 10 min at room temperature the mix was added drop-wise to the cells. Medium was changed to full medium 6 h and cells were treated 24 h posttransfection and harvested.
For microscopy experiments using U2OS cells transfections were carried out according to the manufacturer using FUGene6 (Promega).
siRNA transfections
All cell lines were transfected using HiPerFect (Qiagen), RNAiMAX (Thermo Fisher AGAAAGUGCUGUAGUGCAAdTdT, human siEIF2A #2:
UGUUAAACCCAUUGGUAUAdTdT. siRNAs were either synthesized by Eurofins/MWG or purchased from the indicated supplier.
Generation of stable shRNA knockdown cell lines
Stable HT29 cells were previously described (48) . Two different lentiviral particles (Mission shRNA lentiviral particles (Sigma), #TRCN0000002282 and # TRCN0000002283) together and a control lentiviral particle (Non-Target shRNA Control) were used. After transduction, cells were selected with puromycin (2 µg/mL) for 2 weeks and consequently tested for MK2 expression by Western Blot.
Cloning
A detailed description of the cloning strategy to express MK2 with its full-length 5'UTR is shown in Fig. S5A . The indicated 441 bp 5'UTR-MK2 fragment having NheI and PstI sites was synthesized by GENEART GmbH (Thermo Fisher Scientific). The peGFP-C1-MK2 and pMMP-MK2-IRES-eGFP constructs for expression in mammalian cells and for retroviral transduction were described before (13, 49) .
SDS-PAGE and Western Blot
If not stated differently proteins were separated on 10% SDS acrylamide gels and After incubation at 37°C for 1 hour the solution was transferred to a fresh sample vial. This step was repeated twice and extracts were combined and dried in a vacuum centrifuge. Dried peptide extracts were redissolved in 30 µL 2% ACN, 0.1% TFA with shaking at 800 rpm for 20 min. After centrifugation at 20,000 x g aliquots of 12.5 µL each were stored at -20°C.
Peptide samples were separated with a nano-flow ultra-high pressure liquid chromatography system (RSLC, Thermo Scientific) equipped with a trapping column (3 µm C18 particle, 2 cm length, 75 µm ID, Acclaim PepMap, Thermo Scientific) and a 50 cm long separation column 
MK2 interaction profiling by label-free mass-spectrometry
Per sample 3 to 4 confluent 15 cm dishes of the corresponding MK2 MEFs were either mock-treated (DMSO), pre-treated with the MK2 inhibitor PF3644022 (10µM, Sigma) for 60 minutes or stimulated with Anisomycin (1µg/ml, Sigma) for 30 minutes before lysis.
Approximately 5 mg of lysate was administered to MK2-immunoprecpitations using an agarose MK2-Trap binding resin (Chromotek). Beads were eluted in 2x Laemmli buffer and the resulting supernatants were loaded onto a 4-12% NuPAGE Bis-Tris Gel (Novex, Thermo
Fisher Scientific). Gels were then fixed and stained using the colloidal blue staining kit (Life Technologies/Invitrogen). Gel lanes were sliced into five pieces and proteins were digested in-gel using standard methods (51) . Peptides were reconstituted in 5% CAN 0.1% TFA and analyzed with an Easy-nLC 1200 system (Thermo Scientific) connected to a Fusion Lumos Orbitrap mass spectrometer (Thermo Scientific) through a nanoelectrospray ion source.
Peptides were separated on a 15 cm (75 µm inner diameter) in-house column packed with 1.9
µm reversed-phase C18 beads (Reprosil-Pur AQ, Dr. Maisch), with 45 min gradients. Spray voltage was set to 2kV, capillary temperature to 275˚C and RF level to 30%. A full scan was performed at a resolution of 60,000, with a scan range of 350-1400 m/z, a maximum injection time of 20 ms and with an AGC target of 500,000. Precursors were isolated with a width of 1.3 m/z and precursor fragmentation was accomplished using higher collision dissociation (HCD). Only precursors with charge state 2-5 were considered. MS/MS spectra were acquired in the Orbitrap, and settings included a loop count of 7, a maximum injection time of 118 ms and a resolution of 60,000. Raw MS data were analyzed using MaxQuant software (version 1.6.0.17). Proteins were identified with parameters previously described (52) and quantified using the LFQ algorithm integrated in MaxQuant (53) . Match between runs function was used. Data analysis was performed using Perseus software (54) . Missing values were imputed in all samples using Perseus default settings. Volcano plots were generated by plotting thelog10 transformed FDR-adjusted p-values derived from a two-sided t-test versus log2 transformed fold changed. Significance was determined based on a hyperbolic curve threshold of s0=0.1 using Perseus.
Migration Assay
Fibroblast migration was analyzed by a fluorescence-based scratch wound-healing assay as described previously (45) .
WST-1 Assay
Cell viability assays using WST-1 (water soluble tetrazolium, Roche # 11 644 807 001) were performed as described before (14) .
RNA extraction and qPCR
Total RNA from stimulated cells was extracted using Trizol (Thermo Fisher Afterwards, cells on coverslips were washed three times with 1x PBS before dipping them in MilliQ water and drying them. After complete drying coverslips were mounted on a glass slide in 2.5µl DAPI-containing Vector Shield (Vector Laboratories) mounting medium and fixed on the slide to avoid dissolution. Glass slides were then kept at -20°C until use. Pictures were taken on a Leica DM4 B device using the LasX Software (Leica Microsystems).
Bioinformatic analyses
The indicated data sets were analyzed using the Galaxy Suite (usegalaxy.org) (55) . In brief, raw reads were downloaded from the GEO repository, demultiplexed and converted to the FASTQ format and groomed using "FASTQ Groomer". After adapter-and quality-trimming using "Trim Galore!", the reads were mapped against human hg19 or murine mm10 using "Bowtie2". Aligned reads were then visualized in the Integrative Genomics Viewer (IGV) (56, 57) .
Accession numbers
Nucleotide sequence data reported in this work is available in the Third Party Annotation (TPA) Section of the DDBJ/ENA/GenBank databases.
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Schematic representation of the factors that can influence MK2 translation. We confirmed the need of eIF4A1 to promote translation from the CUG aTIS in the 5'UTR of MK2.
Adenosine Methylation near the stop codon, as shown indirectly by the knockdown of the methyltransferase Mettl3, and depletion of eIF2A had no effect on MK2 translation in our hands. 
